Flyte Aviation (VTAK) Stock Analysis & Price (Updated Oct 15, 2026, 4:00 PM ET)
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.98, +11.36% vs the prior close of $0.88.
- Volume 406.20K shares, 0.6x its 50-day average (light).
- New SEC filings: 8-K (Oct 14, 2026).
- No new insider buys or sales reported since the prior session.
VTAK jumps 11.4% to $0.98. Closed at $0.98, +11.36% vs the prior close of $0.88. Day range $0.83β$0.98, opened at $0.86.
VTAK daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 β VTAK jumps 11.4% to $0.98
- Closed at $0.98, +11.36% vs the prior close of $0.88. Day range $0.83β$0.98, opened at $0.86.
- Volume was 406.20K shares, 0.6x its 50-day average of 698.51K β lighter than usual.
- Price is -46.2% vs its 50-day average ($1.82).
- 52-week range $0.82β$6.40; today's close sits at 3% of that range, 84.7% below the 52-week high.
Oct 14, 2026 β VTAK slides 17.0% to $0.88, a 3-month low on 2.8x normal volume
- Closed at $0.88, -16.98% vs the prior close of $1.06. Day range $0.82β$1.00, opened at $0.95.
- Volume was 1.84M shares, 2.8x its 50-day average of 663.78K β unusually heavy trading.
- Price is -52.6% vs its 50-day average ($1.86).
- 52-week range $0.82β$6.40; today's close sits at 1% of that range, 86.3% below the 52-week high.
- SEC filings that day: 8-K.
Oct 13, 2026 β VTAK jumps 6.0% to $1.06
- Closed at $1.06, +6.00% vs the prior close of $1.00. Day range $0.96β$1.10, opened at $0.99.
- Volume was 854.20K shares, 1.3x its 50-day average of 647.93K.
- Price is -44.1% vs its 50-day average ($1.90).
- 52-week range $0.87β$6.40; today's close sits at 3% of that range, 83.4% below the 52-week high.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 12, 2026 β VTAK slides 12.3% to $1.00
- Closed at $1.00, -12.28% vs the prior close of $1.14. Day range $0.95β$1.10, opened at $1.09.
- Volume was 663.60K shares, 1.0x its 50-day average of 636.09K.
- Price is -48.1% vs its 50-day average ($1.93).
- 52-week range $0.87β$6.40; today's close sits at 2% of that range, 84.4% below the 52-week high.
Oct 9, 2026 β VTAK jumps 12.9% to $1.14
- Closed at $1.14, +12.87% vs the prior close of $1.01. Day range $1.00β$1.14, opened at $1.01.
- Volume was 386.40K shares, 0.6x its 50-day average of 629.71K.
- Price is -41.7% vs its 50-day average ($1.96).
- 52-week range $0.87β$6.40; today's close sits at 5% of that range, 82.2% below the 52-week high.
- SEC filings that day: 8-K.
Oct 8, 2026 β VTAK jumps 8.6% to $1.01
- Closed at $1.01, +8.60% vs the prior close of $0.93. Day range $0.91β$1.05, opened at $0.92.
- Volume was 667.30K shares, 1.1x its 50-day average of 619.03K.
- Price is -49.2% vs its 50-day average ($1.99).
- 52-week range $0.87β$6.40; today's close sits at 3% of that range, 84.2% below the 52-week high.
Oct 7, 2026 β VTAK slides 9.7% to $0.93, a 3-month low
- Closed at $0.93, -9.71% vs the prior close of $1.03. Day range $0.87β$0.98, opened at $0.96.
- Volume was 648.20K shares, 1.1x its 50-day average of 610.85K.
- Price is -54.1% vs its 50-day average ($2.03).
- 52-week range $0.87β$6.40; today's close sits at 1% of that range, 85.5% below the 52-week high.
Oct 6, 2026 β VTAK slides 36.4% to $1.03, a 1-month low on 3.8x normal volume
- Closed at $1.03, -36.42% vs the prior close of $1.62. Day range $0.95β$1.27, opened at $1.23.
- Volume was 2.42M shares, 3.8x its 50-day average of 634.66K β unusually heavy trading.
- Price is -50.1% vs its 50-day average ($2.06).
- 52-week range $0.95β$6.40; today's close sits at 1% of that range, 83.9% below the 52-week high.
Oct 5, 2026 β VTAK jumps 8.0% to $1.62 on 31.8x normal volume
- Closed at $1.62, +8.00% vs the prior close of $1.50. Day range $1.51β$1.70, opened at $1.60.
- Volume was 12.57M shares, 31.8x its 50-day average of 394.71K β unusually heavy trading.
- Price is -22.9% vs its 50-day average ($2.10).
- 52-week range $1.30β$6.40; today's close sits at 6% of that range, 74.7% below the 52-week high.
- SEC filings that day: 8-K.
Oct 2, 2026 β VTAK ends flat (+0.0%) to $1.50
- Closed at $1.50, +0.00% vs the prior close of $1.50. Day range $1.50β$1.60, opened at $1.50.
- Volume was 130.55K shares, 0.3x its 50-day average of 394.25K β lighter than usual.
- Price is -29.2% vs its 50-day average ($2.12).
- 52-week range $1.30β$6.40; today's close sits at 4% of that range, 76.6% below the 52-week high.
- SEC filings that day: 8-K.
VTAK latest news & SEC filings
Every SEC filing by or about VTAK in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Oct 13, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Oct 9, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 3.02 β Sold unregistered shares.
- Item 8.01 β Reported other events the company considers important.
Oct 5, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 β Reported other events the company considers important.
Oct 2, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 3.03 β Change to shareholder rights.
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
- Item 5.03 β Amended its charter or bylaws / changed fiscal year.
- Item 5.07 β Reported shareholder vote results.
- Item 8.01 β Reported other events the company considers important.
Sep 25, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Aug 31, 2026 Β· Form DEF 14A β Proxy statement
Proxy statement β agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 21, 2026 Β· Form 424B3 β Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 21, 2026 Β· Form PRE 14A β Preliminary proxy statement
Preliminary proxy statement
Aug 21, 2026 Β· Form SCHEDULE 13G β Passive stake (13G)
Passive stake (13G) β an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.02M (prior year $212.00K) (+380.7% vs Jun 30, 2025)
- Net income: -$3.29M (prior year -$5.11M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.92 (prior year -$7.28) (loss narrowed vs Jun 30, 2025)
Jul 31, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 3.02 β Sold unregistered shares.
- Item 3.03 β Change to shareholder rights.
- Item 5.03 β Amended its charter or bylaws / changed fiscal year.
Jul 29, 2026 Β· Form 8-K/A β Current report (amended)
Amended current report
- Exhibits / financial statements only (Item 9.01).
Jul 20, 2026 Β· Form SCHEDULE 13G β Passive stake (13G)
Passive stake (13G) β an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 15, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 3.02 β Sold unregistered shares.
- Item 3.03 β Change to shareholder rights.
- Item 5.03 β Amended its charter or bylaws / changed fiscal year.
Things to know before you trade VTAK
- Last results release: Oct 13, 2026 (8-K Item 2.02). Previous ones: May 18, 2026, Mar 31, 2026, Nov 14, 2025. Based on that rhythm, the next report is likely around Jan 12, 2027 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 7.45% (largest 36.4%). That is a volatile stock.
- Liquidity: about 1.07M shares (β$1.05M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.98 vs a range of $0.82β$6.40 (3% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Oct 5, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 14, 2026; 8-K Oct 13, 2026; 8-K Oct 9, 2026.
- Share count: 14.39M shares outstanding (Aug 10, 2026), -38.3% vs a year earlier β the company has been reducing its share count.
- Listing: NYSE Β· industry: Surgical & Medical Instruments & Apparatus.
VTAK market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.86 | 0.98 | 0.83 | 0.98 | 406.20K |
| Oct 14, 2026 | 0.95 | 1.00 | 0.82 | 0.88 | 1.84M |
| Oct 13, 2026 | 0.99 | 1.10 | 0.96 | 1.06 | 854.20K |
| Oct 12, 2026 | 1.09 | 1.10 | 0.95 | 1.00 | 663.60K |
| Oct 9, 2026 | 1.01 | 1.14 | 1.00 | 1.14 | 386.40K |
| Oct 8, 2026 | 0.92 | 1.05 | 0.91 | 1.01 | 667.30K |
| Oct 7, 2026 | 0.96 | 0.98 | 0.87 | 0.93 | 648.20K |
| Oct 6, 2026 | 1.23 | 1.27 | 0.95 | 1.03 | 2.42M |
| Oct 5, 2026 | 1.60 | 1.70 | 1.51 | 1.62 | 12.57M |
| Oct 2, 2026 | 1.50 | 1.60 | 1.50 | 1.50 | 130.55K |
| Oct 1, 2026 | 1.50 | 1.60 | 1.50 | 1.50 | 25.22K |
| Sep 30, 2026 | 1.40 | 1.60 | 1.40 | 1.50 | 83.91K |
| Sep 29, 2026 | 1.50 | 1.50 | 1.40 | 1.40 | 44.63K |
| Sep 28, 2026 | 1.50 | 1.60 | 1.30 | 1.50 | 147.53K |
| Sep 25, 2026 | 1.60 | 1.60 | 1.50 | 1.50 | 61.84K |
| Sep 24, 2026 | 1.60 | 1.60 | 1.50 | 1.60 | 67.56K |
| Sep 23, 2026 | 1.50 | 1.60 | 1.50 | 1.60 | 95.83K |
| Sep 22, 2026 | 1.50 | 1.50 | 1.50 | 1.50 | 49.49K |
| Sep 21, 2026 | 1.50 | 1.50 | 1.40 | 1.50 | 58.85K |
| Sep 18, 2026 | 1.50 | 1.50 | 1.40 | 1.50 | 111.11K |
About Flyte Aviation
Flyte Aviation (VTAK) is listed on the NYSE and classified by the SEC under βSurgical & Medical Instruments & Apparatusβ. Its business address is in FORT MILL, SC. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1716621.
VTAK board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Andrew Arno | Director | Mar 30, 2026 |
| Martin J Colombatto | Director | Mar 30, 2026 |
| James Joseph Caruso | Director | Mar 30, 2026 |
| David A Jenkins | Chairman of the Board and CEO | Mar 30, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Philip J Anderson | Chief Financial Officer | Mar 30, 2026 |
| David A Jenkins | Chairman of the Board and CEO | Mar 30, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
VTAK financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $819.00K | $-17.18M | β | $-8.30M |
| Dec 31, 2024 | $420.00K | $-16.64M | β | $-9.27M |
| Dec 31, 2023 | $442.00K | $-70.57M | β | $-20.62M |
| Dec 31, 2022 | $14.00K | $-26.86M | -25.98 | $-22.57M |
| Dec 31, 2021 | $22.00K | $-25.07M | -248.22 | $-27.62M |
Latest balance sheet: total assets $36.87M, total liabilities $19.73M, cash $643.00K (as of Jun 30, 2026).
VTAK earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 13, 2026 | 8-K Item 2.02 (results) | $1.06 |
| May 18, 2026 | 8-K Item 2.02 (results) | β |
| Mar 31, 2026 | 8-K Item 2.02 (results) | β |
| Nov 14, 2025 | 8-K Item 2.02 (results) | β |
| Aug 11, 2025 | 8-K Item 2.02 (results) | β |
| May 19, 2025 | 8-K Item 2.02 (results) | β |
| Apr 23, 2025 | 8-K Item 2.02 (results) | β |
| Apr 1, 2025 | 8-K Item 2.02 (results) | β |
| Nov 14, 2024 | 8-K Item 2.02 (results) | β |
| Aug 15, 2024 | 8-K Item 2.02 (results) | β |
| Jul 3, 2024 | 8-K Item 2.02 (results) | β |
| May 7, 2024 | 8-K Item 2.02 (results) | β |
Related stocks Β· Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on VTAK
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.